Project CBD

FEBRUARY 27, 2023

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. © Copyright, Project CBD. Pain and therapy vol. Pain and therapy, 10.1007/s40122-022-00465-y. It’s not a new idea. Footnotes Schley, Marcus et al.

THC

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials

FloridaMarijuana.net

AUGUST 15, 2018

While PTSD can be treated with therapies and pharmaceutical medications, those are not always successful and additional treatments are necessary. The compounds THC (tetrahydrocannabinol) and CBD (cannabidiol) found in cannabis signal the same cannabinoid receptors as anandamide.

Treatment

Canna Law Blog

JANUARY 22, 2020

The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Psilocybin!

Clinical Trials

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. At this point, it seems seizure disorders respond best to a range of 27:1 to 15:1 CBD: THC full spectrum cannabis oil. tetrahydrocannabinol (THC).

Conditions

The Joint Blog

NOVEMBER 8, 2020

mg of CBD (both very low numbers). The study concludes by stating that “To our knowledge, this is the first randomized controlled trial to demonstrate the benefit of cannabis oil – a THC-rich whole plant extract – on symptoms and on [the] quality of life of people with fibromyalgia. On average patients received 3.6 mg of THC and 0.08

Clinical Trials

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. So sit back, relax – and if you can’t relax, grab some CBD! What is CBD? Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol.

CBD

Miss Marijuana

MAY 13, 2020

Have you ever asked yourself, “How Much CBD should I take?” If so, here’s what a real life cannabis coach has to say about CBD dosage. Cannabidiol (CBD) is flooding the market and everyone seems to be talking about it. Are you curious about trying CBD? How much CBD should you take and how often? Choosing products.

CBD

Medical Marijuana Program Connection

NOVEMBER 26, 2023

An Israeli startup will be using its proprietary cannabidiol-based therapy in a new clinical trial to treat symptoms experienced by autistic children. SciSparc’s SCI-210 therapy. Read More

Clinical Trials

CannaMD

MAY 25, 2021

In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. THC, CBD & THE ECS. CBD PROMOTES BONE GROWTH. CBD alone is sufficiently effective in enhancing fracture healing.

Marijuana

The Cannigma

FEBRUARY 2, 2021

However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD. Patients can also access CBD products without a prescription through local pharmacies. Still, research is ongoing.

Patients

The Cannigma

JUNE 24, 2021

Countless people now use CBD and other hemp-derived products as part of a prescribed medical regimen, as a daily health supplement, or just a go-to panacea to make the stress of daily life a little bit easier to manage. That doesn’t mean that CBD or other cannabis products should be seen as a cure all on their own.

CBD

Cannabis Law Report

SEPTEMBER 9, 2021

MyMD to highlight its development pipeline for MYMD-1, an immunometabolic regulator, and Supera-CBD, a synthetic cannabidiol derivative. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, will present at the H.C. For more information, visit www.mymd.com.

Pharmaceutical

Cannabis Law Report

JUNE 20, 2021

The CIC consists of 97 members dedicated to ensuring a greater understanding of the role of medicinal cannabis, nutraceutical CBD, and hemp across the community and the advancement of medicinal cannabis as an alternate line of therapy. Patient access.

Supply Chain

Puff Puff Post

DECEMBER 28, 2018

One recent observational study has shown an astonishing success rate of 80% in reducing negative behavioral patterns in test subjects by using CBD oil. We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism.

Treatment

Puff Puff Post

MARCH 10, 2020

INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases. About INM-755: INM-755 is a CBN cream intended as a topical therapy to treat epidermolysis bullosa (EB) and potentially other dermatological diseases.

Clinical Trials

Cannabis Law Report

JANUARY 4, 2022

Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary delivery technology as an Adjunctive Treatment for Opioid Use Disorder. Zaid i , ANANDA’s Chief Executive Officer.

Clinical Trials

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. No approved TNF inhibitor has ever been dosed orally.

Clinical Trials

CannaMD

JUNE 2, 2021

Of those states that had legalized medical marijuana, 14 currently consider Parkinson’s disease a qualifying condition for medical marijuana therapies. A quarter of all users did not know the strain or THC/CBD content of the product they were using. Florida is among these states.

Patients

MMJ Recs

JULY 9, 2024

Disease-modifying therapies (DMTs) are essential in altering the immune response to reduce inflammation and prevent further damage to the nervous system. Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures.

Marijuana

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). ” Using CBD Oil To Treat Seizures. Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. The Next Move Is On The DEA.

Clinical Trials

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. The longitudinal study showed that individuals who used artisanal cannabidiol (CBD) products reported better quality of life, lower psychiatric symptom severity and fewer medication-related adverse events compared with those not using CBD.

Data

Otherside Farms

APRIL 30, 2019

CBD oil is an option. Learn more about CBD oil for stress and anxiety here. We’re talking about CBD. We are going to break down how you can use CBD oil for stress and anxiety and some of the incredible research and scientific evidence backing it up. Why Use CBD Oil for Stress or Anxiety? Let’s begin!

Oil

PrestoDoctor

SEPTEMBER 15, 2023

While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. However, exploring alternative treatment options, such as CBD , alongside traditional therapies can offer individuals with OCD a potential avenue for relief and improved symptom management.

Research and Development

Canna Care Docs

OCTOBER 3, 2023

Natural plant therapy , and cannabis specifically, has been studied for its effectiveness in alleviating and treating many of these physiological and emotional symptoms that come into play with a terminal illness. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.

Chronic Pain

Veriheal

APRIL 11, 2022

I look forward to a time when they are not considered alternative therapies or home remedies but actually first-line therapies,” said the CEO of Zelira, Oludare Odumosu. “We Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials.

Pharmaceutical

MMJ Recs

JULY 11, 2024

Each type of insomnia may require different treatment approaches, including behavioral therapy, medication, lifestyle changes, or addressing underlying medical or psychological issues. However, more robust clinical trials are needed to validate these findings and determine the optimal dosages and treatment regimens for each disorder.

Sleep

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. At this point, it seems seizure disorders respond best to a range of 27:1 to 15:1 CBD: THC full spectrum cannabis oil. tetrahydrocannabinol (THC).

Conditions

PrestoDoctor

OCTOBER 11, 2023

One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Studies have shown that CBD-rich cannabis can help alleviate symptoms such as anxiety, aggression, and social isolation in individuals with ASD. What is CBD?

CBD

Cannabis Law Report

OCTOBER 19, 2021

will discuss the multiple indications for each of MyMD’s novel drug candidates, MYMD-1 and Supera-CBD. Unlike other therapies, MYMD-1 has been shown to selectively block TNF-? About Supera-CBD. A vast majority of CBD developers are pursuing compounds targeted to CB2 that have minimal CB1 affinity. About MYMD-1.

Pharmaceutical

Cannabis Law Report

JULY 8, 2021

NYSE American: YCBD, YCBDpA), one of the leading, and most highly trusted and recognized CBD companies, announced today that its recently formed division, cbdMD Therapeutics, has initiated talks with one of the leading US cannabinoid research institutes, to identify novel cannabinoids for therapeutic use. produced, THC-free 1 CBD products.

Research and Development

Puff Puff Post

OCTOBER 3, 2019

Epidiolex is a CBD-infused oral-based medication designed to help patients as young as two-years-old treat epilepsy disorders. ” The study began last April, and the clinical trial plans to document results on 100 participants, ages 5-18, for the duration of 84 days (12 weeks) of treatments through June 2021. .

Research and Development

MMJ Recs

AUGUST 14, 2024

Traditional treatments, such as medications and physical therapy, usually fall short of providing effective relief. Medical marijuana contains a complex group of compounds known as cannabinoids , primarily THC (tetrahydrocannabinol) and CBD (cannabidiol), which interact with the body’s endocannabinoid system.

Nerve Pain

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA

MMJ Recs

NOVEMBER 30, 2023

The two most well-known compounds in cannabis are tetrahydrocannabinol (THC) and cannabidiol (CBD), each of which has distinct effects on the human body. Studies have indicated that certain cannabinoids found in cannabis, particularly CBD, may have anticonvulsant properties.

Epilepsy

TheAnswerPage

APRIL 27, 2020

Is the US VA Office of research and Development conducting any clinical trials that evaluate the use of CBD for the treatment of PTSD? A RCT evaluating the efficacy of using CBD as an adjunctive to prolonged exposure therapy (PE therapy)) was started in March 2019 and will conclude on September 30,2023.

Clinical Trials

MMJ Recs

JULY 3, 2024

Cannabidiol (CBD) offers a natural alternative for those seeking relief from the symptoms of anxiety and stress. CBD, derived from the cannabis plant, has garnered attention for its potential therapeutic properties without the psychoactive effects commonly associated with tetrahydrocannabinol (THC). What is CBD?

CBD